Emcure Pharmaceuticals shares debut with 31.45% premium

Emcure Pharmaceuticals made a strong debut on the stock exchanges on Wednesday, with shares listing at Rs 1,325 on both NSE and BSE. This marks a 31.45% premium over the issue price of Rs 1,008.

Before the listing, Emcure’s shares were trading at a premium of Rs 360 in the grey market. The company also raised Rs 582 crore from anchor investors ahead of the issue launch.


Qualified institutional buyers (QIBs) led the bidding, subscribing 92.94 times their allotted quota. Non-institutional investors picked up 42.57 times their reserved portion. Employees of Emcure Pharmaceuticals placed bids 7.9 times their allotted quota, while retail investors bought 6.33 times.